Hennion & Walsh Asset Management »

Crispr Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 17k 68.16
2023-12-31 $1.0M 17k 62.60
2023-09-30 $695k 15k 45.39
2023-06-30 $454k 8.1k 56.19

More positions owned by Hennion & Walsh Asset Management

Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Intl Qulty Div (IQDG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Investment Grade (IGEB)
Wisdomtree Tr Us S Cap Qty Div (DGRS)
Nuveen Div. Advantage Muni. Fund (NAD)
Ishares Core Msci Emkt (IEMG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Eli Lilly & Co. (LLY)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Global X Fds Us Pfd Etf (PFFD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)

View all positions for Hennion & Walsh Asset Management

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Morgan Stanley
Bank of America Corporation
Loomis, Sayles and
Dimensional Fund Advisors

View all funds holding Crispr Therapeutics